NCT04101188

Brief Summary

Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jan 2020Jul 2026

First Submitted

Initial submission to the registry

September 23, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 24, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

January 16, 2020

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

6.5 years

First QC Date

September 23, 2019

Last Update Submit

March 2, 2026

Conditions

Keywords

Dietary PotassiumDietary SodiumVascular Health

Outcome Measures

Primary Outcomes (2)

  • Conduit artery endothelial-dependent dilation

    The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD

    on day 10 of the diet

  • Microvascular function

    Cutaneous microvascular dilatory response to local heating assessed by laser Doppler flowmetry coupled with intradermal microdialysis

    on day 10 of the diet

Secondary Outcomes (1)

  • Ambulatory BP monitoring

    on day 7 and 10 of diet

Study Arms (3)

Moderate Potassium/Low Sodium

EXPERIMENTAL

Subjects will be provided with a diet that is moderate in potassium and low in sodium.

Other: Moderate Potassium/Low Sodium Diet

Moderate Potassium/High Sodium

EXPERIMENTAL

Subjects will be provided with a diet that is moderate in potassium and high in sodium.

Other: Moderate Potassium/High Sodium Diet

High Potassium/High Sodium

EXPERIMENTAL

Subjects will be provided with a diet that is high in both potassium and sodium.

Other: High Potassium/High Sodium Diet

Interventions

Consumption of 10 days of a diet moderate in potassium and low in sodium.

Moderate Potassium/Low Sodium

Consumption of 10 days of a diet moderate in potassium and high in sodium.

Moderate Potassium/High Sodium

Consumption of 10 days of a diet high in potassium and high in sodium.

High Potassium/High Sodium

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy
  • normal blood pressure
  • normal resting ECG

You may not qualify if:

  • hypertension
  • history of heart disease
  • diabetes
  • kidney disease
  • obese (BMI ≥30)
  • significant weight changes in the last 6 months
  • use of tobacco products
  • pregnant
  • on a special diet (gluten free; vegan)
  • take any medications for the above conditions
  • endurance trained athletes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Delaware

Newark, Delaware, 19716, United States

RECRUITING

Study Officials

  • Shannon L Lennon, PhD

    University of Delaware

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shannon L Lennon, PhD

CONTACT

Shannon L Lennon, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: All participants will complete each arm. It is a crossover, randomized design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2019

First Posted

September 24, 2019

Study Start

January 16, 2020

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations